Digitisation | May 24, 2022
Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
Dxcover announced that it will be presenting new data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)
Revolutionary ovarian cancer rapid test available Q4 2022
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
Subscribe To Our Newsletter & Stay Updated
